j
u
r
n
l
p
r
e
p
r
f
paolo
pozzilli
md
andrea
lenzi
md
daili
data
show
entir
popul
made
male
differ
number
case
report
gender
increas
progress
favor
male
subject
age
group
except
year
year
group
number
femal
subject
slightli
higher
furthermor
higher
lethal
favor
male
subject
initi
clinic
manifest
pneumonia
though
describ
gastrointestin
symptom
asymptomat
infect
last
yet
definit
assess
infect
progress
sever
diseas
dyspnoea
chest
symptom
correspond
pneumonia
second
third
week
symptomat
infect
clinic
data
show
decreas
oxygen
satur
chang
visibl
chest
xray
imag
techniqu
furthermor
lymphopenia
appear
common
increas
inflammatori
marker
creactiv
protein
proinflammatori
cytokin
report
well
establish
plasma
testosteron
concentr
reduc
age
comorbid
like
obes
diabet
obstruct
sleep
apnea
osa
comorbid
highli
preval
patient
sever
studi
shown
men
chronic
obstruct
pulmonari
diseas
copd
hypogonad
associ
preval
rang
context
low
testosteron
level
caus
reduct
respiratori
muscl
activ
overal
strength
exercis
capac
whilst
normal
circul
testosteron
level
show
protect
effect
sever
respiratori
outcom
ie
forc
expiratori
volum
one
forc
vital
capac
fvc
random
control
trial
report
improv
peak
oxygen
consumpt
men
receiv
testosteron
replac
therapi
infect
lung
alveolar
epitheli
cell
use
entri
receptor
angiotensinconvert
enzym
ii
play
role
lung
protect
therefor
viral
bind
receptor
may
deregul
lung
protect
pathway
interestingli
studi
show
constitut
product
adulttyp
leydig
cell
thu
impli
role
testicular
function
suggest
possibl
involv
testicl
infect
patient
factor
may
affect
testosteron
secret
proinflammatori
cytokin
central
role
progress
infect
reduct
cytokin
activ
andor
receptor
anticytokin
therapi
use
treatment
context
testosteron
may
downregul
inflamm
matter
fact
sever
studi
carri
anim
human
show
hypogonad
associ
increas
proinflammatori
cytokin
testosteron
treatment
reduc
furthermor
associ
increas
j
u
r
n
l
p
r
e
p
r
f
proinflammatori
state
declin
testosteron
often
observ
age
men
men
stabl
coronari
arteri
diseas
base
consider
hypothesi
aris
testosteron
may
role
cascad
event
lead
progress
infect
due
cytokin
storm
suppress
express
inflammatori
cytokin
accompani
decreas
androgen
estrogen
elderli
may
establish
neg
correl
express
mortal
measur
testosteron
level
may
recommend
time
identifi
posit
patient
present
data
testosteron
collect
systemat
one
institut
valu
low
use
testosteron
may
consid
reduc
associ
pulmonari
syndrom
thu
prevent
progress
sever
diseas
proinflammatori
cytokin
play
major
role
select
patient
testosteron
treatment
avoid
enrol
patient
therapi
hormon
contraind
taken
account
proper
random
trial
testosteron
design
oppos
mention
earlier
stand
testosteronedriven
theori
base
androgen
receptor
activ
transcript
transmembran
proteas
serin
explor
possibl
implic
risk
stratif
transmiss
infect
although
proteas
describ
activ
spike
vitro
activ
regard
essenti
viral
spread
pathogenesi
infect
host
may
also
cleav
augment
viral
entri
androgen
receptor
activ
consid
requir
transcript
gene
known
gene
promot
report
exert
action
human
modul
express
testosteron
suggest
contribut
male
predomin
infect
final
frequent
alter
gene
primari
prostat
cancer
critic
factor
enabl
cellular
infect
hyper
adrogen
phenotyp
could
explain
posit
young
male
sever
infect
possibl
shorter
ar
cag
length
greater
risk
develop
prostat
cancer
higher
receptor
transcript
activ
role
variant
express
level
modul
sever
suggest
lead
foster
rapid
experiment
valid
larg
cohort
patient
differ
clinic
manifest
infect
sinc
express
also
pulmonari
level
use
inhibitor
current
use
prostat
cancer
repres
appeal
target
prevent
treatment
pneumonia
studi
requir
valid
hypothesi
evalu
therapeut
prophylact
potenti
drug
temporarili
target
androgen
activ
androgen
receptor
inhibitor
steroidogenesi
inhibitor
reductas
inhibitor
elucid
role
testosteron
battl
toward
infect
turn
urgent
need
